A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
- Submitting institution
-
The University of Leeds
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- UOA1-4691
- Type
- D - Journal article
- DOI
-
10.1136/annrheumdis-2019-215386
- Title of journal
- Annals of the Rheumatic Diseases
- Article number
- -
- First page
- 123
- Volume
- 79
- Issue
- 1
- ISSN
- 0003-4967
- Open access status
- Compliant
- Month of publication
- September
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
13
- Research group(s)
-
-
- Citation count
- 53
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
